Remedy Life Sciences India Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimevog M Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimevog M Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimevog M Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimevog M Tablet.
Glimevog M Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimevog M Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimevog M Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimevog M Tablet contains a combination of three medicines: Glimepiride, Metformin, and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It helps to improve blood glucose levels in adults when taken alongside a healthy diet and regular exercise. Glimepiride lowers blood sugar by increasing insulin release from the pancreas. Metformin decreases glucose production in the liver and enhances insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, helps lower postprandial (after meals) glucose levels. This combination is not suitable for type 1 diabetes treatment.
Possible side effects associated with Glimevog M Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Glimevog M Tablet should not be used in patients with known allergies to any of its components or excipients. Individuals with moderate to severe kidney disease and those with inflammatory bowel diseases, colonic ulcers, or underlying metabolic acidosis (including diabetic ketoacidosis) must avoid this medication.
No, alcohol consumption is not advised when using Glimevog M Tablet. Alcohol can lower blood sugar levels and increase the risk of lactic acidosis.
Yes, Glimevog M Tablet can potentially cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications along with it. Regular monitoring of blood sugar levels is crucial, and always keep glucose tablets, honey, or fruit juice on hand.
Store the medication in its original packaging, tightly sealed. Follow instructions from the label or packaging. Discard unused medication responsibly. Ensure it is not accessible to pets, children, or other individuals.